-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOFRONTERA INC - TO PRESENT PHASE 2B DATA TO FDA IN Q3 2026 FOR AMELUZ PDT

Reuters·03/09/2026 13:15:00

Please log in to view news